Previous studies have found that drugs can activate the PI3K/AKT/mTOR and DNA damage repair pathways, and the combined application of PKI-587 can inhibit the activation of these two pathways, thereby enhancing the sensitivity of tumor cells to drugs [28]. The gene discussed is AKT1; the disease is neoplasm.